Your session is about to expire
← Back to Search
Behavioural Intervention
Blood Flow Restriction Exercise for Multiple Sclerosis (BFR-MS Trial)
N/A
Waitlist Available
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at baseline (week 0) and post test (week 9)
Awards & highlights
BFR-MS Trial Summary
This trial is testing whether 8 weeks of physical therapy exercises using BFR may help improve walking in people with MS who have moderate-to-severe walking problems.
Eligible Conditions
- Multiple Sclerosis
BFR-MS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measured at baseline (week 0) and post test (week 9)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at baseline (week 0) and post test (week 9)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in ankle plantarflexion muscle strength
Change in hip abduction muscle strength
Change in knee extension muscle strength
Secondary outcome measures
Change in 12-Item MS Walking Scale
Change in 30-second sit-to-stand completions
Change in Berg Balance Scale
+5 moreBFR-MS Trial Design
1Treatment groups
Experimental Treatment
Group I: Blood Flow Restriction ExerciseExperimental Treatment1 Intervention
Participant will participate in a supervised low load blood flow restriction exercise program twice a week for 8 weeks.
Find a Location
Who is running the clinical trial?
Consortium of Multiple Sclerosis CentersOTHER
8 Previous Clinical Trials
50,144 Total Patients Enrolled
8 Trials studying Multiple Sclerosis
50,144 Patients Enrolled for Multiple Sclerosis
University of Colorado, DenverLead Sponsor
1,735 Previous Clinical Trials
2,149,156 Total Patients Enrolled
20 Trials studying Multiple Sclerosis
2,752 Patients Enrolled for Multiple Sclerosis
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger